02.08.2024
With the rapid development of medical technology, electrical stimulation therapy, as a non-invasive, low-risk and effective treatment, is gradually demonstrating its unique advantages in various fields such as neurological rehabilitation, pain management, and treatment of psychological disorders. Nanochap, with its innovative NNC6121 highly integrated and programmable stimulation chip, is leading the way for electrical stimulation devices to become more intelligent, personalized and efficient.
Nanochap's NNC6121 is a major breakthrough in the field of electrical stimulation technology. It integrates an ARM microcontroller, a configurable boost DC converter, and a multi-channel, highly flexible stimulation driver circuit, realizing an unprecedented high degree of integration. This design not only dramatically reduces the size of the device and production costs, but more critically, improves system stability and reliability, ensuring precise control and safety during the stimulation process.
Even more remarkable is the programmability of the NNC6121 chip. Through the dedicated programming interface, users can flexibly configure and adjust the working parameters of the chip, such as stimulation waveform, frequency, pulse width, amplitude, etc., according to the specific therapeutic needs, so as to realize the fine regulation of the output of electrical stimulation. At the same time, the NNC6121 provides two types of boost circuits: built-in MOS boost circuits and external MOS boost circuits. This high degree of flexibility and customizability allows the NNC6121 chip to easily adapt to a variety of electrical stimulation equipment application scenarios to meet the individual needs of different patients.
The NNC6121 chip is able to provide a single-channel stimulation current output of up to 67mA and support more than three stimulation waveforms, which are optimized for different types of diseases and symptoms based on extensive clinical research and practical experience. For example, for neurological rehabilitation patients, continuous or pulsed waveforms can be selected to stimulate damaged nerves and promote neuron regeneration and repair; for chronic pain patients, modulated or complex waveforms can be used to alleviate pain and improve quality of life by adjusting the stimulation parameters.
In addition, NNC6121 chip adopts constant current source technology, which can control the stimulation current more stably, and at the same time, the current waveform output from the constant current source can maintain a relatively stable state after entering the human body. The traditional constant voltage source technology is prone to cause changes in the current waveform into the body, which may cause damage to the surrounding tissues in the body, and more deeply affect the nerve signal conduction and processing.
Thanks to the highly integrated and programmable nature of the NNC6121 chip, Nanochap's electrical stimulation devices can be applied in a wider range of fields. In the field of neurological rehabilitation, from simple muscle exercise to complex nerve retraining, the NNC6121 chip can provide powerful support; in pain management, whether acute pain or chronic pain, can be effectively relieved through the appropriate stimulation mode; in addition, in the treatment of psychological diseases, beauty and body care, etc., the NNC6121 chip has also shown great potential for application.
Nanochap will continue to work on the development and optimization of the NNC6121 chip as medical technology advances and patient needs become more and more diverse. We look forward to seeing more innovative technologies, such as artificial intelligence and big data analysis, which will enable electrical stimulation devices to more intelligently identify the patient's therapeutic needs and automatically adjust the stimulation parameters to achieve more precise and personalized therapeutic effects.